Banque Cantonale Vaudoise’s Co-Diagnostics CODX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$0	Hold	6	–	–	﹤0.01%	799
2024 Q2	$0	Hold	6	–	–	﹤0.01%	1004
2024 Q1	$0	Hold	6	–	–	﹤0.01%	1002
2023 Q4	$0	Hold	6	–	–	﹤0.01%	1061
2023 Q3	$0	Hold	6	–	–	﹤0.01%	1186
2023 Q2	$0	Hold	6	–	–	﹤0.01%	1185
2023 Q1	$0	Hold	6	–	–	﹤0.01%	1187
2022 Q4	$0	Hold	6	–	–	﹤0.01%	1198
2022 Q3	$1K	Hold	6	–	–	﹤0.01%	1216
2022 Q2	$1K	Hold	6	–	–	﹤0.01%	1262
2022 Q1	$1K	Hold	6	–	–	﹤0.01%	1273
2021 Q4	$2K	Hold	6	–	–	﹤0.01%	1281
2021 Q3	$2K	Hold	6	–	–	﹤0.01%	1250
2021 Q2	$1K	Hold	6	–	–	﹤0.01%	1231
2021 Q1	$2K	Hold	6	–	–	﹤0.01%	1133
2020 Q4	$2K	Hold	6	–	–	﹤0.01%	1058
2020 Q3	$2K	Hold	6	–	–	﹤0.01%	1042
2020 Q2	$3K	Buy	+6	New	+$2.74K	﹤0.01%	890

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

Banque Cantonale Vaudoise's CODX Position: Q3 2024 in Review

Banque Cantonale Vaudoise held its Co-Diagnostics (CODX) position steady in Q3 2024 at 6 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #799.

Banque Cantonale Vaudoise first reported a position in CODX in Q2 2020 and has held it in 18 quarters since. The position peaked at $3K in Q2 2020. 36 funds tracked by Wall St. Rank hold CODX as of Q3 2024.

Banque Cantonale Vaudoise held 6 shares of Co-Diagnostics worth $0 as of Q3 2024.
Banque Cantonale Vaudoise left its Co-Diagnostics share count unchanged in Q3 2024.
Co-Diagnostics made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q3 2024, its #799 holding.
Banque Cantonale Vaudoise first reported a position in Co-Diagnostics in Q2 2020 and has held it in 18 quarters since.
Banque Cantonale Vaudoise's Co-Diagnostics position peaked at $3K in Q2 2020.
36 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.